EDIT Jan 2025 15.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 09:58AM EDT
| Previous Close | 0.1000 |
| Open | 0.2000 |
| Bid | 0.0000 |
| Ask | 0.4500 |
| Strike | 15.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.1000 - 0.2000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 412 |
ZacksEditas (EDIT) Down 17% Since Last Earnings Report: Can It Rebound?
Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GlobeNewswireEditas Medicine to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that management will participate in the following upcoming investor conferences to discuss the Company and its programs, including reni-cel: Morgan Stanley 22nd Annual Global Healthcare ConferenceFormat: Fireside ChatDate: Wednesday, September 4Time: 4:05 p.m. ETLocation: New York, NY 2024 Wells Fargo Healthcare ConferenceFormat: Fireside ChatDate: Thur
Simply Wall St.We're Keeping An Eye On Editas Medicine's (NASDAQ:EDIT) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
© 2024 Yahoo. All rights reserved.